BIOBLAST PHARMA

Bio Blast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases. Bio Blast Pharma Ltd. was founded in 2012 and is headquartered in Tel Aviv, Israel. The board has approved the nomination of the following individuals to serve as members of the Board, effective on July 31: Gili Cohen; Eyal Gibor; Tomer Yossef; and Ran Weinstock. All the new members of the board qualify as independent directors under applicable Nasdaq rules.
BIOBLAST PHARMA
Industry:
Biotechnology Genetics Health Care
Founded:
2012-01-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.bioblast-pharma.com
Total Employee:
11+
Status:
Active
Contact:
+972 72-240-9060
Total Funding:
4.75 M USD
Technology used in webpage:
Domain Not Resolving IPv6 Cloudflare Hosting ASP.NET Cloudflare DNS Google Analytics Classic
Similar Organizations
CureGenetics
Cure Genetics is a biotechnology company that develops innovative medicines & molecular diagnostics to treat cancers & genetic diseases.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Founder
Stock Details
Official Site Inspections
http://www.bioblast-pharma.com
- Host name: 172.67.138.186
- IP address: 172.67.138.186
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "BioBlast Pharma"
Pipeline - Bioblast Pharma
At Bioblast Pharma, we develop innovative treatment of organ failure associated with Sepsis and COVID-19, prevention of post-bone marrow transplantations (BMT) complications and solid โฆSee details»
BioBlast Pharma - Crunchbase Company Profile & Funding
Bio Blast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases. Bio Blast Pharma Ltd. was founded in 2012 and is โฆSee details»
Bioblast Pharma - Israeli Startup | Startup Nation Finder
Bioblast Pharma is a biotechnology company that develops therapies for patients with rare and ultra-rare genetic diseases. The company is building a diverse portfolio of product candidates โฆSee details»
Organization | Bioblast Pharma Ltd.
Organization Overview. First Clinical Trial. 2014 NCT02015481. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Bioblast Pharma Ltd. Active Ingredients. Drugs in โฆSee details»
BioBlast Pharma - Crunchbase
Bio Blast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases. New. Resources. ... Experience the new โฆSee details»
About Our Company - Bioblast Pharma
Bioblast Pharma provides you with the remedies for particular illnesses involving the same pathogens. Taking into account the concern of modern sciences and health professionals in โฆSee details»
Bioblast Pharma Ltd. - Cruelty Free Investing
Bioblast Pharma Ltd (BioBlast) is an Israel-based development-stage biopharmaceutical company. The Company is focused on the identification, licensing, acquisition, development โฆSee details»
Bioblast Pharma - 2025 Company Profile - Tracxn
Feb 24, 2025 Bioblast Pharma - Israeli clinical-stage Biotech developing therapeutics for rare and ultra-rare genetic diseases.. Public Company. Raised a total funding of $4.75M over 1 โฆSee details»
BioBlast Pharma Strengthens Leadership Team and Announces Key ...
Nov 19, 2015 BioBlast Pharma is a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases.See details»
BioBlast Pharma - VentureRadar
BioBlast Pharma manufactures Trehalose, a therapeutic to potentially treat a number of devastating PolyA/PolyQ diseases. Trehalose acts as a chemical chaperone to protects โฆSee details»
Bioblast Pharmaceuticals - Hope Should Not Be Rare
Bioblast pharmaceuticals represents a reputable company specializing in the researches of biotechnologies as well as development of clinically approved treatment solutions for patients โฆSee details»
BioBlast Pharma - Overview, News & Similar companies - ZoomInfo
Feb 18, 2019 BioBlast Pharma is a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic โฆSee details»
BioBlast Pharma - PitchBook
BioBlast Pharma General Information Description. Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and โฆSee details»
BioBlast Pharma - Funding, Financials, Valuation & Investors
Bio Blast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases. Search Crunchbase Start Free TrialSee details»
Bioblast Pharma Company Information - Funding, Investors, and โฆ
Get information on funding, investors, industries, and more for Bioblast Pharma. See Bioblast Pharma company profile and funding data.See details»
Our Investors - Bioblast Pharma
The total investment of Bioblast Pharma in the project at the first stage, including the cost of equipping the laboratory with equipment, will amount to about $200 million by the end of 2020. โฆSee details»
Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed โฆ
Mar 28, 2019 Enlivex completed on Tuesday its merger with Tel Aviv-headquartered Bioblast Pharma Ltd., a Nasdaq-listed clinical-stage company developing treatments for rare genetic โฆSee details»
Support and Resources - Bioblast Pharma
Bioblast Pharma drug prequalification program also performs prequalification of pharmaceutical ingredients and quality control in laboratories. This service is required to assess the quality, โฆSee details»
The Orphan Genetic Disease Company - Bioblast Pharma
Bioblast Pharma Ltd. June 2016 . Forward-Looking Statements This presentation includes statements that are, or may be deemed, โโforward-looking statements.โโ In some cases, these โฆSee details»